ThePharmYard > Global BioGenerics Market in 2010: A Consensus Market Models report

Click here to see all Urch Publishing titles in ThePharmYard

Pay-as-you-go medical and pharmaceutical industry information

About Us | Contact Us | Terms

Managed by NetworkPharma

The Publishers // Urch Publishing

Global BioGenerics Market in 2010: A Consensus Market Models report

Using proprietary methodology, this Consensus Market Model report analyses the potential market for BioGenerics products by the year 2010. The report will provide you with the necessary insight to make informed decisions about this exciting market.

Product Details - See below for further product information
Note the document you buy is licensed for your own use only.

File type and size: 0.289 MB
Publication size: 52 pages
Publication date: November 2005
Published by: Urch Publishing
ThePharmYard product code: urch015

Our Price: £495.00
You are buying an e-document. This is a digital product and therefore UK VAT @ 17.50 % will be added at Checkout if your billing address is in the EU.

Related Products:

The saga of the legal framework for biogenerics in Europe

Assessing the economics of biogenerics

Pharmacists' views on generic medicines: A review of the literature

Opportunities and challenges in an ever generic world

Generics Threats And Opportunities: Mounting an Effective Defense Strategy - 2nd Edition

Further Product Information

SUMMARY

BioGenerics is an umbrella term used to define the market for bioequivalent products based on the same biological substance used in off-patent biologics. The BioGeneric market is set to develop slowly in the major pharmaceutical markets, as a result of regulatory hurdles and continued protectionism from patented biopharmaceutical marketers. Once the market does begin to evolve, the biogeneric companies entering the market early will derive significant value.

Using a proprietary methodology, this Consensus Market Model report analyses the potential market for BioGenerics products by the year 2010. The 50 page report will provide you with the necessary insight to make informed decisions about this extremely exciting market.

"Biopharmaceuticals are set to win market share not only in monetary terms but also in numbers of products on the market"

Key findings of this report

A Consensus Market Model forecast for the global BioGenerics market in 2010 of $2.3 billion

Current off-patent blockbusters including erythropoietin, represent an excellent opportunity

Significant obstacles associated with manufacturing and marketing BioGenerics has reduced the number of potential BioGenerics companies to less than ten

A key market event is the launch of Omnitrop in Australia in late 2005 or early 2006

Why read this report

Understand key market conditions that underpin the future of BioGeneric products

Assess the current market research and analysis from a broad range of sources

Learn how regulatory authorities are shaping the market

Gain insight into which companies are working in this area

CONTENTS

Executive Summary
Market Analysis
Market Forecast

1. Market Definitions & Scope
Market definitions
Market scope
Market evolution

2. Market Sizing
Current market reach
Current market size
R&D activity

3. Market Segmentation
Key geographies
Key market segments
Key companies

4. Key Market Trends
Historical trends
Future trend projections

5. Critical Market Events
First key event: Approval and launch of first biogeneric, Omnitrop(e)
Second key event: US clarification of biogenerics regulation
Third key event: Growing number of patent expiries

6. Future Market Scenarios
Best case market scenario
Worst case market scenario
Most likely market scenario

7. Future Market Forecasts
Forecasting methodology
Base case forecast
Best and worse case scenarios
Sources

Strategic Medcomms Forum 2010:
Reshaping the healthcare conversation

30 September 2010

Oxford University Museum of Natural History, Oxford, UK

Learn more here

What we do

ThePharmYard sells information relevant to the medical and pharmaceutical industries, on behalf of independent publishers, in the form of e-documents. Buy online now and access the information immediately.

If you have any problems or questions or comments of any sort, then do please contact us directly.

All transactions conducted independently by WorldPay

basket

checkout

terms

Browse all publications in ThePharmYard from Urch Publishing.

Selected Special Offers

1. Venlafaxine in Depression (in Primary Care)

2. Tiotropium in COPD (in Primary Care)

3. Pravastatin in Lipid Disorders (in Primary Care)

4. Escitalopram in Depression (in Primary Care)

5. Nicorandil in Angina (in Primary Care)

Our Best Sellers

1. An overview of CME/CPD credit systems around the world

2. Mifepristone (RU-486) treatment for depression and psychosis: a review of the therapeutic implications

3. Stepping up to Medical Sales Success - 2nd Edition

4. Quid Pro Quo Deals

5. Bipolar disorder - Disease overview

6. Bipolar disorder - Improving Practice (UK)

7. Olanzapine in bipolar disorder - Drug review

8. Developing Win-Win Key Opinion Leader Relationships

9. Levocetirizine in Allergic Rhinitis (in Primary Care)

10. Customer-Driven Positioning: The next generation approach to pharmaceutical product positioning

Latest Additions

1. Future of European Pharmaceutical Distribution

2. Global Dental Implants Market (2010 -2015)

3. Discretion is the better part of value: Five research-based rules for ensuring that strategy implementers implement

4. The competitive environment and hospital performance: An empirical investigation

5. Antecedents, environmental moderators and consequences of market orientation: A study of pharmaceutical firms in Ghana

Need help?

If you can't find what you are looking for, or have any problems or questions or comments at all, then please contact us directly.

If you are an Author or Publisher and have one or more publications you would like to make available to our specialist medical and pharmaceutical industry audience, then please contact us directly.

If you run your own web site and want to earn money from our affiliate scheme then please contact us directly.

Affiliates | About Us | Contact Us | Terms

ThePharmYard is an initiative for the international medical and pharmaceutical industries from NetworkPharma Ltd. Copyright 2010

Other services managed by NetworkPharma: [www.EuropeanCMEforum.eu] [www.KeywordPharma.com] [www.MedCommsForum.com] [www.MedCommsNetworking.co.uk] [www.NetworkPharma.tv] [www.ThePublicationPlan.com]

We accept the following credit and debit cards: amex visa visa_delta visa_electron mastercard switch jcb solo